Peak Pharmaceuticals (OTCMKTS:PKPH) Shares Down 3.2% – What’s Next?

Peak Pharmaceuticals, Inc. (OTCMKTS:PKPH – Get Free Report)’s stock price dropped 3.2% on Tuesday . The company traded as low as $0.77 and last traded at $1.21. Approximately 11,145 shares changed hands during trading, an increase of 23% from the average daily volume of 9,053 shares. The stock had previously closed at $1.25.

Peak Pharmaceuticals Price Performance

The business has a fifty day moving average of $2.22 and a 200-day moving average of $2.97.

About Peak Pharmaceuticals

(Get Free Report)

Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.

Further Reading

• Five stocks we like better than Peak Pharmaceuticals
• Russell 2000 Index, How Investors Use it For Profitable Trading
• Palantir Cracks $50, Is There Still Time to Get on Board?
• Natural Gas Prices Continue To Rally, These Stocks Should Benefit
• Insider Buying Signals Upside for These 3 Stocks
• Biggest Stock Losers – Today’s Biggest Percentage Decliners
• These 2 Big Players Are Set to Compete With Elon Musk’s Starlink